Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies.

Stem cells international

Reale A, Melaccio A, Lamanuzzi A, Saltarella I, Dammacco F, Vacca A, Ria R.
PMID: 26788072
Stem Cells Int. 2016;2016:7954580. doi: 10.1155/2016/7954580. Epub 2015 Dec 14.

It was believed that vasculogenesis occurred only during embryo life and that postnatal formation of vessels arose from angiogenesis. Recent findings demonstrate the existence of Endothelial Precursor Cells (EPCs), which take partin postnatal vasculogenesis. EPCs are recruited from the...

Cite
Reale A, Melaccio A, Lamanuzzi A, et al. Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies. Stem Cells Int. 2015;2016:7954580doi: 10.1155/2016/7954580.
Reale, A., Melaccio, A., Lamanuzzi, A., Saltarella, I., Dammacco, F., Vacca, A., & Ria, R. (2016). Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies. Stem cells international, 20167954580. https://doi.org/10.1155/2016/7954580
Reale, Antonia, et al. "Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies." Stem cells international vol. 2016 (2016): 7954580. doi: https://doi.org/10.1155/2016/7954580
Reale A, Melaccio A, Lamanuzzi A, Saltarella I, Dammacco F, Vacca A, Ria R. Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies. Stem Cells Int. 2016;2016:7954580. doi: 10.1155/2016/7954580. Epub 2015 Dec 14. PMID: 26788072; PMCID: PMC4691637.
Copy Download .nbib Format: NLM
Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers.

International journal of oncology

Vacca A, Ribatti D, Gasparini G, Fanelli M, Minischetti M, Ritelli G, Costantino F, Iurlaro M, Bonoldi E, Dammacco F.
PMID: 21544397
Int J Oncol. 1996 Mar;8(3):561-6. doi: 10.3892/ijo.8.3.561.

We evaluated the microvessel area (an index of angiogenesis) by using the factor VIII-related antigen (factor VIII-RA), and the expression of three components of the subendothelial basement membrane, namely: tenascin, laminin and type IV collagen. The four markers were...

Cite
Vacca A, Ribatti D, Gasparini G, et al. Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers. Int J Oncol. 1996;8(3):561-6doi: 10.3892/ijo.8.3.561.
Vacca, A., Ribatti, D., Gasparini, G., Fanelli, M., Minischetti, M., Ritelli, G., Costantino, F., Iurlaro, M., Bonoldi, E., & Dammacco, F. (1996). Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers. International journal of oncology, 8(3), 561-6. https://doi.org/10.3892/ijo.8.3.561
Vacca, A, et al. "Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers." International journal of oncology vol. 8,3 (1996): 561-6. doi: https://doi.org/10.3892/ijo.8.3.561
Vacca A, Ribatti D, Gasparini G, Fanelli M, Minischetti M, Ritelli G, Costantino F, Iurlaro M, Bonoldi E, Dammacco F. Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers. Int J Oncol. 1996 Mar;8(3):561-6. doi: 10.3892/ijo.8.3.561. PMID: 21544397.
Copy Download .nbib Format: NLM
Spontaneous diaphragmatic rupture following neoadjuvant chemotherapy and cytoreductive surgery in malignant pleural mesothelioma: A case report and review of the literature.

International journal of surgery case reports

Cattaneo M, Mendogni P, Damarco F, Tosi D.
PMID: 32988786
Int J Surg Case Rep. 2020;77:S85-S87. doi: 10.1016/j.ijscr.2020.09.073. Epub 2020 Sep 16.

INTRODUCTION: Diaphragmatic rupture (DR) is an acquired diaphragmatic defect that can cause herniation of abdominal organs into the chest. It is usually a trauma-related lesion, but rarely it can occur spontaneously. Every DR with abdominal herniation should be considered...

Cite
Cattaneo M, Mendogni P, Damarco F, et al. Spontaneous diaphragmatic rupture following neoadjuvant chemotherapy and cytoreductive surgery in malignant pleural mesothelioma: A case report and review of the literature. Int J Surg Case Rep. 2020;77:S85-S87doi: 10.1016/j.ijscr.2020.09.073.
Cattaneo, M., Mendogni, P., Damarco, F., & Tosi, D. (2020). Spontaneous diaphragmatic rupture following neoadjuvant chemotherapy and cytoreductive surgery in malignant pleural mesothelioma: A case report and review of the literature. International journal of surgery case reports, 77S85-S87. https://doi.org/10.1016/j.ijscr.2020.09.073
Cattaneo, Margherita, et al. "Spontaneous diaphragmatic rupture following neoadjuvant chemotherapy and cytoreductive surgery in malignant pleural mesothelioma: A case report and review of the literature." International journal of surgery case reports vol. 77 (2020): S85-S87. doi: https://doi.org/10.1016/j.ijscr.2020.09.073
Cattaneo M, Mendogni P, Damarco F, Tosi D. Spontaneous diaphragmatic rupture following neoadjuvant chemotherapy and cytoreductive surgery in malignant pleural mesothelioma: A case report and review of the literature. Int J Surg Case Rep. 2020;77:S85-S87. doi: 10.1016/j.ijscr.2020.09.073. Epub 2020 Sep 16. PMID: 32988786; PMCID: PMC7876689.
Copy Download .nbib Format: NLM
The European experience.

Journal of thoracic disease

Tosi D, Palleschi A, Musso V, Mazzucco A, Cattaneo M, Carrinola R, Damarco F, Mendogni P.
PMID: 32642267
J Thorac Dis. 2020 Jun;12(6):3411-3417. doi: 10.21037/jtd.2020.01.26.

Traditionally, pulmonary lobectomy has always been considered as the gold standard for the treatment of early stage non-small cell lung cancer (NSCLC); limited resections have been proposed in case of "compromised" patients, with relevant comorbidities. In the last years,...

Cite
Tosi D, Palleschi A, Musso V, et al. The European experience. J Thorac Dis. 2020;12(6):3411-3417doi: 10.21037/jtd.2020.01.26.
Tosi, D., Palleschi, A., Musso, V., Mazzucco, A., Cattaneo, M., Carrinola, R., Damarco, F., & Mendogni, P. (2020). The European experience. Journal of thoracic disease, 12(6), 3411-3417. https://doi.org/10.21037/jtd.2020.01.26
Tosi, Davide, et al. "The European experience." Journal of thoracic disease vol. 12,6 (2020): 3411-3417. doi: https://doi.org/10.21037/jtd.2020.01.26
Tosi D, Palleschi A, Musso V, Mazzucco A, Cattaneo M, Carrinola R, Damarco F, Mendogni P. The European experience. J Thorac Dis. 2020 Jun;12(6):3411-3417. doi: 10.21037/jtd.2020.01.26. PMID: 32642267; PMCID: PMC7330796.
Copy Download .nbib Format: NLM
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.

Mediterranean journal of hematology and infectious diseases

Ria R, Dammacco F, Vacca A.
PMID: 29326807
Mediterr J Hematol Infect Dis. 2018 Jan 01;10(1):e2018011. doi: 10.4084/MJHID.2018.011. eCollection 2018.

The heavy chain diseases (HCDs) are rare B-cell malignancies characterized by the production of a monoclonal immunoglobulin heavy chain without an associated light chain. There are three types of HCD, defined by the class of immunoglobulin heavy chain produced:...

Cite
Ria R, Dammacco F, Vacca A. Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update. Mediterr J Hematol Infect Dis. 2018;10(1):e2018011doi: 10.4084/MJHID.2018.011.
Ria, R., Dammacco, F., & Vacca, A. (2018). Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update. Mediterranean journal of hematology and infectious diseases, 10(1), e2018011. https://doi.org/10.4084/MJHID.2018.011
Ria, Roberto, et al. "Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update." Mediterranean journal of hematology and infectious diseases vol. 10,1 (2018): e2018011. doi: https://doi.org/10.4084/MJHID.2018.011
Ria R, Dammacco F, Vacca A. Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update. Mediterr J Hematol Infect Dis. 2018 Jan 01;10(1):e2018011. doi: 10.4084/MJHID.2018.011. eCollection 2018. PMID: 29326807; PMCID: PMC5760076.
Copy Download .nbib Format: NLM
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.

Medicine

Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F, Sansonno D.
PMID: 23982056
Medicine (Baltimore). 2013 Sep;92(5):245-256. doi: 10.1097/MD.0b013e31829d2abc.

We evaluated the influence of cryoglobulinemic syndrome (CS) on the outcome of chronic hepatitis C virus (HCV) infection in a 15-year prospective study. We assessed a cohort of 950 chronically HCV-infected patients, collected from the beginning of 1990 to...

Cite
Lauletta G, Russi S, Conteduca V, et al. Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. Medicine (Baltimore). 2013;92(5):245-256doi: 10.1097/MD.0b013e31829d2abc.
Lauletta, G., Russi, S., Conteduca, V., Sansonno, L., Dammacco, F., & Sansonno, D. (2013). Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. Medicine, 92(5), 245-256. https://doi.org/10.1097/MD.0b013e31829d2abc
Lauletta, Gianfranco, et al. "Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study." Medicine vol. 92,5 (2013): 245-256. doi: https://doi.org/10.1097/MD.0b013e31829d2abc
Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F, Sansonno D. Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. Medicine (Baltimore). 2013 Sep;92(5):245-256. doi: 10.1097/MD.0b013e31829d2abc. PMID: 23982056; PMCID: PMC4553977.
Copy Download .nbib Format: NLM
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents.

International journal of clinical and experimental medicine

Ria R, Reale A, Moschetta M, Mangialardi G, Dammacco F, Vacca A.
PMID: 23236556
Int J Clin Exp Med. 2013;6(1):30-8. Epub 2012 Nov 18.

BACKGROUND: The large majority of patients with multiple myeloma develop bone lesions and typically receive bisphosphonates to maintain bone health and prevent/delay skeletal-related events. Recent clinical data show that the newer-generation bisphosphonate, zoledronic acid, may confer a survival benefit...

Cite
Ria R, Reale A, Moschetta M, et al. A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents. Int J Clin Exp Med. 2012;6(1):30-8
Ria, R., Reale, A., Moschetta, M., Mangialardi, G., Dammacco, F., & Vacca, A. (2013). A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents. International journal of clinical and experimental medicine, 6(1), 30-8.
Ria, Roberto, et al. "A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents." International journal of clinical and experimental medicine vol. 6,1 (2013): 30-8.
Ria R, Reale A, Moschetta M, Mangialardi G, Dammacco F, Vacca A. A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents. Int J Clin Exp Med. 2013;6(1):30-8. Epub 2012 Nov 18. PMID: 23236556; PMCID: PMC3515976.
Copy Download .nbib Format: NLM
RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes.

Clinical ophthalmology (Auckland, N.Z.)

Mavilio A, Sisto D, Ferreri P, Dammacco R, Alessio G.
PMID: 31440021
Clin Ophthalmol. 2019 Jul 24;13:1315-1322. doi: 10.2147/OPTH.S211337. eCollection 2019.

PURPOSE: To evaluate reliability of steady-state pattern electroretinogram (ssPERG) phase variability in re-test (procedure called RE-PERG) in the presence of myopia, which is known to affect ssPERG amplitude, in glaucomatous patients (GP), normal controls (NC), and myopic patients (MY).METHODS:...

Cite
Mavilio A, Sisto D, Ferreri P, et al. RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes. Clin Ophthalmol. 2019;13:1315-1322doi: 10.2147/OPTH.S211337.
Mavilio, A., Sisto, D., Ferreri, P., Dammacco, R., & Alessio, G. (2019). RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes. Clinical ophthalmology (Auckland, N.Z.), 131315-1322. https://doi.org/10.2147/OPTH.S211337
Mavilio, Alberto, et al. "RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes." Clinical ophthalmology (Auckland, N.Z.) vol. 13 (2019): 1315-1322. doi: https://doi.org/10.2147/OPTH.S211337
Mavilio A, Sisto D, Ferreri P, Dammacco R, Alessio G. RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes. Clin Ophthalmol. 2019 Jul 24;13:1315-1322. doi: 10.2147/OPTH.S211337. eCollection 2019. PMID: 31440021; PMCID: PMC6664252.
Copy Download .nbib Format: NLM
Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

International ophthalmology

Dammacco R, Guerriero S, Alessio G, Dammacco F.
PMID: 34802085
Int Ophthalmol. 2021 Nov 21; doi: 10.1007/s10792-021-02058-8. Epub 2021 Nov 21.

PURPOSE: To provide an overview of the ocular features of rheumatoid arthritis (RA) and of the ophthalmic adverse drug reactions (ADRs) that may be associated with the administration of antirheumatic drugs.METHODS: A systematic literature search was performed using the...

Cite
Dammacco R, Guerriero S, Alessio G, et al. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review. Int Ophthalmol. 2021;doi: 10.1007/s10792-021-02058-8.
Dammacco, R., Guerriero, S., Alessio, G., & Dammacco, F. (2021). Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review. International ophthalmology, . https://doi.org/10.1007/s10792-021-02058-8
Dammacco, Rosanna, et al. "Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review." International ophthalmology vol. (2021). doi: https://doi.org/10.1007/s10792-021-02058-8
Dammacco R, Guerriero S, Alessio G, Dammacco F. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review. Int Ophthalmol. 2021 Nov 21; doi: 10.1007/s10792-021-02058-8. Epub 2021 Nov 21. PMID: 34802085.
Copy Download .nbib Format: NLM
The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia.

Ocular immunology and inflammation

Dammacco R, Lisch W, Kivelä TT, Terpos E, Kastritis E, Sisto D, Mavilio A, Ria R, Alessio G, Vacca A, Dammacco F.
PMID: 34270382
Ocul Immunol Inflamm. 2021 Jul 16;1-10. doi: 10.1080/09273948.2021.1933068. Epub 2021 Jul 16.

No abstract available.

Cite
Dammacco R, Lisch W, Kivelä TT, et al. The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia. Ocul Immunol Inflamm. 2021;1-10doi: 10.1080/09273948.2021.1933068.
Dammacco, R., Lisch, W., Kivelä, T. T., Terpos, E., Kastritis, E., Sisto, D., Mavilio, A., Ria, R., Alessio, G., Vacca, A., & Dammacco, F. (2021). The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia. Ocular immunology and inflammation, 1-10. https://doi.org/10.1080/09273948.2021.1933068
Dammacco, Rosanna, et al. "The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia." Ocular immunology and inflammation vol. (2021): 1-10. doi: https://doi.org/10.1080/09273948.2021.1933068
Dammacco R, Lisch W, Kivelä TT, Terpos E, Kastritis E, Sisto D, Mavilio A, Ria R, Alessio G, Vacca A, Dammacco F. The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia. Ocul Immunol Inflamm. 2021 Jul 16;1-10. doi: 10.1080/09273948.2021.1933068. Epub 2021 Jul 16. PMID: 34270382.
Copy Download .nbib Format: NLM
A 10-year-old immunocompetent girl with endogenous fungal endophthalmitis: Report of a case and review of the literature.

European journal of ophthalmology

Guerriero S, Dammacco R, Albano V, Rizzo T, Cassano F, Boscia F, Alessio G.
PMID: 34405721
Eur J Ophthalmol. 2021 Aug 18;11206721211037825. doi: 10.1177/11206721211037825. Epub 2021 Aug 18.

Endogenous Endophthalmitis (EE) is a rare cause of blindness in the pediatric age group and this may account for the paucity of management guidelines in the literature. In this report, we describe our experience with a 10-year-old immunocompetent female...

Cite
Guerriero S, Dammacco R, Albano V, et al. A 10-year-old immunocompetent girl with endogenous fungal endophthalmitis: Report of a case and review of the literature. Eur J Ophthalmol. 2021;11206721211037825doi: 10.1177/11206721211037825.
Guerriero, S., Dammacco, R., Albano, V., Rizzo, T., Cassano, F., Boscia, F., & Alessio, G. (2021). A 10-year-old immunocompetent girl with endogenous fungal endophthalmitis: Report of a case and review of the literature. European journal of ophthalmology, 11206721211037825. https://doi.org/10.1177/11206721211037825
Guerriero, Silvana, et al. "A 10-year-old immunocompetent girl with endogenous fungal endophthalmitis: Report of a case and review of the literature." European journal of ophthalmology vol. (2021): 11206721211037825. doi: https://doi.org/10.1177/11206721211037825
Guerriero S, Dammacco R, Albano V, Rizzo T, Cassano F, Boscia F, Alessio G. A 10-year-old immunocompetent girl with endogenous fungal endophthalmitis: Report of a case and review of the literature. Eur J Ophthalmol. 2021 Aug 18;11206721211037825. doi: 10.1177/11206721211037825. Epub 2021 Aug 18. PMID: 34405721.
Copy Download .nbib Format: NLM
MicroRNAs to know in Waldenstrom macroglobulinemia.

Blood

Vacca A, Dammacco F.
PMID: 19406998
Blood. 2009 Apr 30;113(18):4133-4. doi: 10.1182/blood-2009-01-199828.

No abstract available.

Cite
Vacca A, Dammacco F. MicroRNAs to know in Waldenstrom macroglobulinemia. Blood. 2009;113(18):4133-4doi: 10.1182/blood-2009-01-199828.
Vacca, A., & Dammacco, F. (2009). MicroRNAs to know in Waldenstrom macroglobulinemia. Blood, 113(18), 4133-4. https://doi.org/10.1182/blood-2009-01-199828
Vacca, Angelo, and Dammacco, Franco. "MicroRNAs to know in Waldenstrom macroglobulinemia." Blood vol. 113,18 (2009): 4133-4. doi: https://doi.org/10.1182/blood-2009-01-199828
Vacca A, Dammacco F. MicroRNAs to know in Waldenstrom macroglobulinemia. Blood. 2009 Apr 30;113(18):4133-4. doi: 10.1182/blood-2009-01-199828. PMID: 19406998.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries